CRISPR Medicine News
Business News
About CRISPR Medicine News
Welcome to CRISPR Medicine News.
We are a global independent online media writing about gene therapy and genome editing.
Read more.
CLINICAL TRIALS
IND Enabling
Phase I
Phase II
Phase III
IND Enabling
Phase I
Phase II
Phase III
Relapsed or Refractory Acute Myeloid Leukemia, AML, (NCT06128044)
Sponsors:
Caribou Biosciences, Inc.
Sponsors:
Caribou Biosciences, Inc.

IND Enabling
Phase I
Phase II
Phase III